Nykredit A S Makes New Investment in ResMed Inc. $RMD
MarketBeat
Nykredit A/S has made a significant new investment in ResMed Inc. (NYSE:RMD), purchasing 338,702 shares valued at approximately $66 million in the second quarter. This move aligns with other institutional investors increasing their stakes, bringing total institutional ownership to nearly 55%. Despite a "Hold" consensus rating from analysts, ResMed has shown strong financial performance, exceeding earnings expectations, and recently increased its quarterly dividend.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.